Wei Lin - Researcher Profile | RDL Research Database

Publications

2 shown

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

Leora Horn , Aaron S. Mansfield , Aleksandra Szczęsna +18 more

The addition of atezolizumab to chemotherapy in the first-line treatment of extensive-stage small-cell lung cancer resulted in significantly longer overall survival and progress...

2018 New England Journal of Medicine 3263 citations

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial

Howard West , Michael McCleod , Maen Hussein +17 more

Atezolizumab (a monoclonal antibody against PD-L1), which restores anticancer immunity, improved overall survival in patients with previously treated non-small-cell lung cancer ...

2019 The Lancet Oncology 1597 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 4,860
Institution: German Center for Lung Research

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-8643-594X

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.